The Role of CMAs in Quality by Design (QbD): Quality cannot be tested into a product. It must be designed into it. In the QbD paradigm, Critical Material Attributes (CMAs) are the variables that determine whether that design holds or collapses when raw materials arrive at your dock.
CMA vs. CQA: Understanding the Difference in Pharmaceutical Technology Transfer: Conflating input material attributes with output product characteristics is a quiet but persistent source of scale-up failure.
Is Science the true starting point for innovation? Discover why the linear model is failing and how the dynamic cycle of Manufacturing, Science, and Technology Transfer is the real engine of progress.
The journey to the GMP lab of the future is not without its obstacles. These challenges require careful planning, significant investment, and a willingness to embrace change at every level of the organization.
The biopharmaceutical industry stands at the intersection of groundbreaking innovation and stringent regulatory compliance.